Results 81 to 90 of about 1,625,836 (186)

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

open access: yes, 2011
Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hyperglycemia, dyslipidemia and the metabolic syndrome) that are associated with an increased risk of type 2 diabetes mellitus and cardiovascular disease ...
De Hert, Marc   +10 more
core   +1 more source

Evaluation of cardiometabolic monitoring in patients taking antipsychotic agents within a community health system. [PDF]

open access: yes
Presented at the ASHP Midyear Clinical Meeting. New Orleans, LA This evaluation found that the majority of patients on antipsychotic agents do not have all baseline monitoring completed, and that there are significant gaps especially in lipid panel and ...
Nguyen, Quyen, PharmD, BCACP   +4 more
core   +1 more source

Does augmentation with antipsychotic agents affect the medication adherence of the child with obsessive-compulsive disorder?

open access: yes, 2019
Antipsychotic agents can be used for augmentation when the response to treatment is insufficient in children with obsessive compulsive disorder.
Tayfun Kara   +7 more
core   +1 more source

Proportion of High-dose Antipsychotic Therapy and Prescription Pattern in Patients Diagnosed with Schizophrenia from a Tertiary Care Hospital in Nepal: An Observational Study

open access: yesJournal of Nepal Medical Association
Introduction: High-dose antipsychotic therapy, defined as dosing exceeding 100% of the British National Formulary recommended  maximum daily dose, is associated with increased risk of adverse effects and is generally discouraged by clinical guidelines ...
Lujaw Ratna Tuladhar   +3 more
doaj   +1 more source

Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation.

open access: yes, 2008
The present study investigated the effects of second generation antipsychotics (SGA) on the metabolism of 15 antipsychotic-naïve outpatients. Evaluations were performed at baseline and after 1 month of treatment. A significant increase in mean body mass
BERARDI, DOMENICO   +8 more
core   +1 more source

Assessment and Management of Antipsychotic-Induced Adverse Events

open access: yes, 1998
Objective: To review and discuss the spectrum of adverse events caused by antipsychotic agents that can directly influence the outcome of treatment by interfering with patient acceptance of and adherence to therapy.
Richard Williams   +2 more
core   +1 more source

Therapeutic drug monitoring of atypical antipsychotic drugs

open access: yes, 2014
Schizophrenia is a severe psychiatric disorder often associated with cognitive impairment and affective, mainly depressive, symptoms. Antipsychotic medication is the primary intervention for stabilization of acute psychotic episodes and prevention of ...
Urinovska Romana   +2 more
core   +1 more source

Case Report: Paralytic ileus as an early manifestation of evolving neuroleptic malignant syndrome in a patient receiving anti-psychotics

open access: yesFrontiers in Medicine
Neuroleptic malignant syndrome (NMS) is an uncommon, but potentially life- threatening complication of antipsychotic therapy, primarily resulting from central dopaminergic blockade.
Balakrishnan Arivalagan   +8 more
doaj   +1 more source

Impact of Early Antipsychotic Prescription Choice on Weight Gain in the First 5 Years of Psychotic Illness: a Retrospective Cohort Study

open access: yesNeurology and Therapy
Introduction We analysed the effects of antipsychotic drug prescribing in year 1 of treatment for psychosis on future weight gain over 5 years. Methods We studied how weight changed over 5 years after the first diagnosis of psychosis/schizophrenia ...
Adrian Heald   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy